article thumbnail

BioNTech’s RNA vaccine sparks potential in pancreatic cancer

Pharmaceutical Technology

In the study, 16 patients were treated with a vaccine called autogene cevumeran that contained a maximum of 20 neoantigens, alongside Roche’s anti-PD-L1 immunotherapy Tecentriq (atezolizumab). The vaccine, developed by BioNTech, led to half of the patients with pancreatic cancer in the Phase I trial remaining cancer-free 18 months later.

RNA 345
article thumbnail

Tetra and Cellvera partner to develop oral Covid-19 treatment

Pharmaceutical Technology

A first-in-human drug product, ARDS-003 contains the active pharmaceutical agent, Onternabez. A selective viral RNA-dependent RNA polymerase (RdRP) inhibitor, Favipiravir has antiviral activity against single-stranded RNA viruses, such as coronaviruses. Qifenda is a broad-spectrum antiviral drug in the commercial stage.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Moderna’s founder launches Laronde, promising new ‘Endless RNA’ drug class

pharmaphorum

Flagship Pioneering, the VC fund run by Moderna’s co-founder Noubar Afeyan has launched a new biotech Laronde , with an ambitious plan to create a new class of drugs based on Endless RNA. The post Moderna’s founder launches Laronde, promising new ‘Endless RNA’ drug class appeared first on.

RNA 98
article thumbnail

Newly discovered RNA molecules hold promise for detecting and treating esophageal cancer

Medical Xpress

But most genetic material contains elements whose function isn't clear. Irregularities in the body's genetic coding to make proteins are linked to cancerous tumors.

RNA 117
article thumbnail

Moderna signs contract to supply Covid-19 booster vaccines to the US

Pharmaceutical Technology

4/5 strain messenger RNA (mRNA). The mRNA-1273.222 vaccine containing the BA.4/5 The contract comprises a $1.74bn award to produce and supply these vaccine doses and options to further procure up to 234 million additional doses of the company’s booster candidates. Another vaccine, mRNA-1273.214, comprises the BA.1

Vaccine 289
article thumbnail

mRNA drugs with a built-in ‘copy machine’ could lead to safer, more effective therapies

STAT News

This story has been adapted from the STAT Report “The future of messenger RNA: Covid-19 vaccines are just the beginning.” ” R emember that messenger-RNA-based Covid-19 vaccine you got? Just a few days later, the teeny molecular messengers contained in the shot were already gone. Read the rest…

RNA 105
article thumbnail

New discovery shows human cells can write RNA sequences into DNA

Scienmag

In a discovery that challenges long-held dogma in biology, researchers show that mammalian cells can convert RNA sequences back into DNA, a feat more common in viruses than eukaryotic cells PHILADELPHIA – Cells contain machinery that duplicates DNA into a new set that goes into a newly formed cell.

DNA 58